Gilead CEO John C. Martin - CEO pay report

John C. Martin

John C. Martin - Gilead

Total Compensation: $10.8 million

Details: Martin received roughly $1 million in salary, $1.6 million in bonuses and $3,800 in "other" compensation. Most of Martin's slary came from stock and option awards valued at about $10.1 million. Overall, Martin's compensation fell 6.8 percent from 2006.

Gilead News:
FDA approves Letairis
Gilead touts Phase III Hep B results

Gilead CEO John C. Martin - CEO pay report
Read more on

Suggested Articles

Robertson, M.D., who led global development teams within Shire’s neuroscience division, is now Yumanity Therapeutics’ chief medical officer.

Novo Nordisk and Dicerna are teaming up on liver-related diseases, including nonalcoholic steatohepatitis (NASH), to the tune of $225 million.

After announcing it was slashing scores of jobs, Alkermes is now willing to put down nearly $1 billion to buy out CNS biotech Rodin Therapeutics.